Which information on women's issues in epilepsy does a community pharmacist need to know? A Delphi consensus study

Epilepsy and Behavior

Volumn 77, Issue , 2017, Pages 79-89

  Shawahna, Ramzi ^a  

^a AN NAJAH NATIONAL UNIVERSITY   (Palestine)

Author keywords

Antiepileptic drugs; Epilepsy; Knowledge; Pharmacists; Pregnancy; Women's issues

Indexed keywords

FOLIC ACID; VITAMIN K GROUP; ANTICONVULSIVE AGENT;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BONE CHARACTERISTICS AND FUNCTIONS; BREAST FEEDING; CATAMENIAL EPILEPSY; CONSENSUS; CONTRACEPTION; COUNSELING; DELPHI STUDY; DISEASE ASSOCIATION; ECLAMPSIA; EPILEPSY; FEMALE; HEALTH EDUCATION; HEALTH SERVICE; HORMONE SUBSTITUTION; HUMAN; INFERTILITY; KNOWLEDGE; MALE; MENOPAUSE; MENSTRUATION DISORDER; OBSERVATIONAL STUDY; PHARMACIST; PREGNANCY; PREPREGNANCY CARE; QUESTIONNAIRE; SEXUALITY; SOCIAL HIERARCHY; TERATOGENICITY; WOMEN'S HEALTH; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; PSYCHOLOGY; YOUNG ADULT;

ADULT; ANTICONVULSANTS; BREAST FEEDING; CONSENSUS; CONTRACEPTION; EPILEPSY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MENOPAUSE; PHARMACISTS; PREGNANCY; PREGNANCY COMPLICATIONS; YOUNG ADULT;

EID: 85033228777     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2017.09.026     Document Type: Article

References (151)

1. Suto, H.S., Braga, G.C., Scarpellini, G.R., Takeuchi, L.I., Martins, A.P., Leite, J.P., et al. Neurologist knowledge about interactions between antiepileptic drugs and contraceptive methods. Int J Gynaecol Obstet 134 (2016), 264–267.
2. Bangar, S., Shastri, A., El-Sayeh, H., Cavanna, A.E., Women with epilepsy: clinically relevant issues. Funct Neurol 31 (2016), 127–134.
3. Fiest, K.M., Sauro, K.M., Wiebe, S., Patten, S.B., Kwon, C.S., Dykeman, J., et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology 88 (2017), 296–303.
4. Thurman, D.J., Beghi, E., Begley, C.E., Berg, A.T., Buchhalter, J.R., Ding, D., et al. Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia 52:Suppl. 7 (2011), 2–26.
5. England, M.J., Liverman, C.T., Schultz, A.M., Strawbridge, L.M., Epilepsy across the spectrum: promoting health and understanding. A summary of the Institute of Medicine report. Epilepsy Behav 25 (2012), 266–276.
6. Kobau, R., Zahran, H., Thurman, D.J., Zack, M.M., Henry, T.R., Schachter, S.C., et al. Epilepsy surveillance among adults—19 states, behavioral risk factor surveillance system, 2005. MMWR Surveill Summ 57 (2008), 1–20.
7. McAuley, J.W., Anderson, G.D., Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations. Clin Pharmacokinet 41 (2002), 559–579.
8. McAuley, J.W., Casey, J., Long, L., An evaluation of pharmacists' knowledge of women's issues in epilepsy. Epilepsy Behav 14 (2009), 243–246.
9. Shawahna, R., Atrash, A., Jebril, A., Khalaf, A., Shaheen, E., Tahboosh, H., Evaluation of pharmacists' knowledge of women's issues in epilepsy: a cross-sectional study in Palestinian pharmacy practice. Seizure 46 (2017), 1–6.
10. Thomas, S.V., Management of epilepsy and pregnancy. J Postgrad Med 52 (2006), 57–64.
11. Saramma, P.P., Sarma, P.S., Thomas, S.V., Women with epilepsy have poorer knowledge and skills in child rearing than women without epilepsy. Seizure 20 (2011), 575–579.
12. Kaplan, P.W., Norwitz, E.R., Ben-Menachem, E., Pennell, P.B., Druzin, M., Robinson, J.N., et al. Obstetric risks for women with epilepsy during pregnancy. Epilepsy Behav 11 (2007), 283–291.
13. Meador, K.J., Pennell, P.B., Harden, C.L., Gordon, J.C., Tomson, T., Kaplan, P.W., et al. Pregnancy registries in epilepsy: a consensus statement on health outcomes. Neurology 71 (2008), 1109–1117.
14. Fairgrieve, S.D., Jackson, M., Jonas, P., Walshaw, D., White, K., Montgomery, T.L., et al. Population based, prospective study of the care of women with epilepsy in pregnancy. BMJ 321 (2000), 674–675.
15. Holmes, L.B., The teratogenicity of anticonvulsant drugs: a progress report. J Med Genet 39 (2002), 245–247.
16. Pennell, P.B., Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?. Epilepsia 49:Suppl. 9 (2008), 43–55.
17. Prinjha, S., Chapple, A., Herxheimer, A., McPherson, A., Many people with epilepsy want to know more: a qualitative study. Fam Pract 22 (2005), 435–441.
18. Lewis, R., Dixon, J., Rethinking management of chronic diseases. BMJ 328 (2004), 220–222.
19. McKinstry, B., Do patients wish to be involved in decision making in the consultation? A cross sectional survey with video vignettes. BMJ 321 (2000), 867–871.
20. Kunneman, M., Pieterse, A.H., Stiggelbout, A.M., Marijnen, C.A., Which benefits and harms of preoperative radiotherapy should be addressed? A Delphi consensus study among rectal cancer patients and radiation oncologists. Radiother Oncol 114 (2015), 212–217.
21. Dunn, J., Steginga, S.K., Rose, P., Scott, J., Allison, R., Evaluating patient education materials about radiation therapy. Patient Educ Couns 52 (2004), 325–332.
22. Guleser, G.N., Tasci, S., Kaplan, B., The experience of symptoms and information needs of cancer patients undergoing radiotherapy. J Cancer Educ 27 (2012), 46–53.
23. Hack, T.F., Degner, L.F., Parker, P.A., The communication goals and needs of cancer patients: a review. Psychooncology 14 (2005), 831–845 [discussion 846-7].
24. Doughty, J., Baker, G.A., Jacoby, A., Lavaud, V., Cross-cultural differences in levels of knowledge about epilepsy. Epilepsia 44 (2003), 115–123.
25. Poole, K., Moran, N., Bell, G., Solomon, J., Kendall, S., McCarthy, M., et al. Patients' perspectives on services for epilepsy: a survey of patient satisfaction, preferences and information provision in 2394 people with epilepsy. Seizure 9 (2000), 551–558.
26. Vazquez, B., Gibson, P., Kustra, R., Epilepsy and women's health issues: unmet needs—survey results from women with epilepsy. Epilepsy Behav 10 (2007), 163–169.
27. Crawford, P., Lee, P., Gender difference in management of epilepsy-what women are hearing. Seizure 8 (1999), 135–139.
28. McAuley, J.W., Miller, M.A., Klatte, E., Shneker, B.F., Patients with epilepsy's perception on community pharmacist's current and potential role in their care. Epilepsy Behav 14 (2009), 141–145.
29. McAuley, J., Mott, D., Schommer, J., Moore, J., Reeves, A., Assessing the needs of community pharmacists and primary care physicians in providing care to patients with epilepsy. J Am Pharm Assoc 39 (1999), 499–504.
30. Krauss, G.L., Brandt, J., Campbell, M., Plate, C., Summerfield, M., Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians. Neurology 46 (1996), 1534–1539.
31. Roth, Y., Neufeld, M.Y., Blatt, I., Guy-Alfandary, S., Rasaby, S., Ekstein, D., et al. An evaluation of pharmacist knowledge on treatment with antiepileptic drugs. Seizure 34 (2016), 60–65.
32. Long, L., McAuley, J.W., Shneker, B., Moore, J.L., The validity and reliability of the Knowledge of Women's Issues and Epilepsy (KOWIE) Questionnaires I and II. J Neurosci Nurs 37 (2005), 88–91.
33. Long, L., Montouris, G., Knowledge of women's issues and epilepsy (KOWIE-II): a survey of health care professionals. Epilepsy Behav 6 (2005), 90–93.
34. Harden, C.L., Pennell, P.B., Koppel, B.S., Hovinga, C.A., Gidal, B., Meador, K.J., et al. Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 73 (2009), 142–149.
35. Duffield, C., The Delphi technique: a comparison of results obtained using two expert panels. Int J Nurs Stud 30 (1993), 227–237.
36. Hasson, F., Keeney, S., McKenna, H., Research guidelines for the Delphi survey technique. J Adv Nurs 32 (2000), 1008–1015.
37. Shawahna, R., Taha, A., Which potential harms and benefits of using ginger in the management of nausea and vomiting of pregnancy should be addressed? A consensual study among pregnant women and gynecologists. BMC Complement Altern Med, 17, 2017, 204.
38. Shawahna, R., Haddad, A., Khawaja, B., Raie, R., Zaneen, S., Edais, T., Medication dispensing errors in Palestinian community pharmacy practice: a formal consensus using the Delphi technique. Int J Clin Pharmacol 38 (2016), 1112–1123.
39. Shawahna, R., Masri, D., Al-Gharabeh, R., Deek, R., Al-Thayba, L., Halaweh, M., Medication administration errors from a nursing viewpoint: a formal consensus of definition and scenarios using a Delphi technique. J Clin Nurs 25 (2016), 412–423.
40. Shawahna, R., Rahman, N.U., Ahmad, M., Debray, M., Yliperttula, M., Decleves, X., Electronic prescribing reduces prescribing error in public hospitals. J Clin Nurs 20 (2011), 3233–3245.
41. Ghaleb, M.A., Barber, N., Dean Franklin, B., Wong, I.C., What constitutes a prescribing error in paediatrics?. Qual Saf Health Care 14 (2005), 352–357.
42. Dean, B., Barber, N., Schachter, M., What is a prescribing error?. Qual Health Care 9 (2000), 232–237.
43. Page, A., Potter, K., Clifford, R., McLachlan, A., Etherton-Beer, C., Prescribing for Australians living with dementia: study protocol using the Delphi technique. BMJ Open, 5, 2015, e008048.
44. McKenna, H.P., The Delphi technique: a worthwhile research approach for nursing?. J Adv Nurs 19 (1994), 1221–1225.
45. Keeney, S., Hasson, F., McKenna, H., Consulting the oracle: ten lessons from using the Delphi technique in nursing research. J Adv Nurs 53 (2006), 205–212.
46. Pennell, P.B., Use of antiepileptic drugs during pregnancy: evolving concepts. Neurotherapeutics 13 (2016), 811–820.
47. Pennell, P.B., Gidal, B.E., Sabers, A., Gordon, J., Perucca, E., Pharmacology of antiepileptic drugs during pregnancy and lactation. Epilepsy Behav 11 (2007), 263–269.
48. Pennell, P.B., Using current evidence in selecting antiepileptic drugs for use during pregnancy. Epilepsy Curr 5 (2005), 45–51.
49. Gedzelman, E., Meador, K.J., Antiepileptic drugs in women with epilepsy during pregnancy. Ther Adv Drug Saf 3 (2012), 71–87.
50. Crawford, P., Best practice guidelines for the management of women with epilepsy. Epilepsia 46:Suppl. 9 (2005), 117–124.
51. Ruth, D.J., Barnett, J., Epilepsy in pregnancy: best evidence for care. J Perinat Neonatal Nurs 27 (2013), 217–224.
52. Luef, G., Tauboll, E., Gender issues in epilepsy—difference in management of epilepsy. Seizure 28 (2015), 1–2.
53. Morrell, M.J., Sarto, G.E., Shafer, P.O., Borda, E.A., Herzog, A., Callanan, M., Health issues for women with epilepsy: a descriptive survey to assess knowledge and awareness among healthcare providers. J Womens Health Gend Based Med 9 (2000), 959–965.
54. Kampman, M.T., Johansen, S.V., Stenvold, H., Acharya, G., Management of women with epilepsy: are guidelines being followed? Results from case-note reviews and a patient questionnaire. Epilepsia 46 (2005), 1286–1292.
55. Tomson, T., Perucca, E., Battino, D., Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy. Epilepsia 45 (2004), 1171–1175.
56. Roberts, J.I., Metcalfe, A., Abdulla, F., Wiebe, S., Hanson, A., Federico, P., et al. Neurologists' and neurology residents' knowledge of issues related to pregnancy for women with epilepsy. Epilepsy Behav 22 (2011), 358–363.
57. Borthen, I., Obstetrical complications in women with epilepsy. Seizure 28 (2015), 32–34.
58. Steinhoff, B.J., Pregnancy, epilepsy, and anticonvulsants. Dialogues Clin Neurosci 10 (2008), 63–75.
59. Pennell, P.B., Pregnancy, epilepsy, and women's issues. Continuum (Minneap Minn) 19 (2013), 697–714.
60. McGrath, A., Sharpe, L., Lah, S., Parratt, K., Pregnancy-related knowledge and information needs of women with epilepsy: a systematic review. Epilepsy Behav 31 (2014), 246–255.
61. Lee, S.M., Nam, H.W., Kim, E.N., Shin, D.W., Moon, H.J., Jeong, J.Y., et al. Pregnancy-related knowledge, risk perception, and reproductive decision making of women with epilepsy in Korea. Seizure 22 (2013), 834–839.
62. Widnes, S.F., Schjott, J., Granas, A.G., Risk perception and medicines information needs in pregnant women with epilepsy—a qualitative study. Seizure 21 (2012), 597–602.
63. Vajda, F.J., O'Brien, T.J., Lander, C.M., Graham, J., Roten, A., Eadie, M.J., Teratogenesis in repeated pregnancies in antiepileptic drug-treated women. Epilepsia 54 (2013), 181–186.
64. Eadie, M.J., Treating epilepsy in pregnant women. Expert Opin Pharmacother 15 (2014), 841–850.
65. Crawford, P., Hudson, S., Understanding the information needs of women with epilepsy at different lifestages: results of the ‘Ideal World’ survey. Seizure 12 (2003), 502–507.
66. Gooneratne, I.K., Wimalaratna, S., Update on management of epilepsy in women for the non-neurologist. Postgrad Med J 92 (2016), 554–559.
67. Weckesser, A., Denny, E., Women living with epilepsy, experiences of pregnancy and reproductive health: a review of the literature. Seizure 22 (2013), 91–98.
68. Noe, K.H., Pack, A.M., Women's issues and epilepsy. Continuum (Minneap Minn) 16 (2010), 159–178.
69. Tettenborn, B., Genton, P., Polson, D., Epilepsy and women's issues: an update. Epileptic Disord 4:Suppl. 2 (2002), S23–31.
70. Liporace, J.D., Women's issues in epilepsy. Menses, childbearing, and more. Postgrad Med 102 (1997), 123–124 [127-9, 133-5 passim].
71. Adab, N., Kini, U., Vinten, J., Ayres, J., Baker, G., Clayton-Smith, J., et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75 (2004), 1575–1583.
72. Arpino, C., Brescianini, S., Robert, E., Castilla, E.E., Cocchi, G., Cornel, M.C., et al. Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia 41 (2000), 1436–1443.
73. Artama, M., Auvinen, A., Raudaskoski, T., Isojarvi, I., Isojarvi, J., Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 64 (2005), 1874–1878.
74. Brodie, M.J., Mintzer, S., Pack, A.M., Gidal, B.E., Vecht, C.J., Schmidt, D., Enzyme induction with antiepileptic drugs: cause for concern?. Epilepsia 54 (2013), 11–27.
75. Calabrò, R.S., Lamotrigine-induced persistent genital arousal disorder: an unusual side effect. Epilepsy Behav 68 (2017), 234–235.
76. Chaiworapongsa, T., Chaemsaithong, P., Yeo, L., Romero, R., Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 10 (2014), 466–480.
77. Cornelissen, M., Steegers-Theunissen, R., Kollee, L., Eskes, T., Motohara, K., Monnens, L., Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency. Am J Obstet Gynecol 168 (1993), 884–888.
78. Davis, A.R., Pack, A.M., Dennis, A., Contraception for women with epilepsy. Allen, R.H., Cwiak, C.A., (eds.) Contraception for the medically challenging patient, 2014, Springer New York, New York, NY, 135–146.
79. Dean, P., Austin, J.K., Adolescent psychosocial issues in epilepsy. Clin Nurs Pract Epilepsy 3 (1996), 4–6.
80. Euser, A.G., Cipolla, M.J., Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke 40 (2009), 1169–1175.
81. Foldvary-Schaefer, N., Falcone, T., Catamenial epilepsy: pathophysiology, diagnosis, and management. Neurology 61 (2003), S2–15.
82. Gauthier, A.C., Mattson, R.H., Clobazam: a safe, efficacious, and newly rediscovered therapeutic for epilepsy. CNS Neurosci Ther 21 (2015), 543–548.
83. Gerard, E.E., Haut, S., Patel, P., Sazgar, M., Change in seizure pattern and menopause. Controversies in caring for women with epilepsy, 2016, Springer, 141–152.
84. Harden, C.L., Sexuality in men and women with epilepsy. CNS Spectr 11 (2006), 13–18.
85. Herzog, A.G., Disorders of reproduction in patients with epilepsy: primary neurological mechanisms. Seizure 17 (2008), 101–110.
86. Herzog, A.G., Catamenial epilepsy: update on prevalence, pathophysiology and treatment from the findings of the NIH Progesterone Treatment Trial. Seizure 28 (2015), 18–25.
87. Herzog, A.G., Differential impact of antiepileptic drugs on the effects of contraceptive methods on seizures: interim findings of the epilepsy birth control registry. Seizure 28 (2015), 71–75.
88. Herzog, A.G., MacEachern, D.B., Mandle, H.B., Cahill, K.E., Fowler, K.M., Davis, A.R., et al. Folic acid use by women with epilepsy: findings of the epilepsy birth control registry. Epilepsy Behav 72 (2017), 156–160.
89. Honein, M.A., Paulozzi, L.J., Mathews, T.J., Erickson, J.D., Wong, L.Y., Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285 (2001), 2981–2986.
90. Hovinga, C.A., Asato, M.R., Manjunath, R., Wheless, J.W., Phelps, S.J., Sheth, R.D., et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav 13 (2008), 316–322.
91. Hovinga, C.A., Pennell, P.B., Chapter 14 antiepileptic drug therapy in pregnancy II. Int Rev Neurobiol 83 (2008), 241–258.
92. Isojarvi, J.I., Laatikainen, T.J., Pakarinen, A.J., Juntunen, K.T., Myllyla, V.V., Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 329 (1993), 1383–1388.
93. Johnston, C.A., Crawford, P.M., Anti-epileptic drugs and hormonal treatments. Curr Treat Options Neurol, 16, 2014, 288.
94. Kaplan, Y.C., Nulman, I., Koren, G., Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP Epilepsy and Pregnancy Registry. Ther Drug Monit 37 (2015), 557–558.
95. Karabiber, H., Sonmezgoz, E., Ozerol, E., Yakinci, C., Otlu, B., Yologlu, S., Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid. Brain Dev 25 (2003), 113–115.
96. Klein, P., Serje, A., Pezzullo, J.C., Premature ovarian failure in women with epilepsy. Epilepsia 42 (2001), 1584–1589.
97. Kothare, S.V., Kaleyias, J., The adverse effects of antiepileptic drugs in children. Expert Opin Drug Saf 6 (2007), 251–265.
98. Krämer, G., Biraben, A., Carreno, M., Guekht, A., de Haan, G.J., Jędrzejczak, J., et al. Current approaches to the use of generic antiepileptic drugs. Epilepsy Behav 11 (2007), 46–52.
99. Laxer, K.D., Trinka, E., Hirsch, L.J., Cendes, F., Langfitt, J., Delanty, N., et al. The consequences of refractory epilepsy and its treatment. Epilepsy Behav 37 (2014), 59–70.
100. Lim, L.L., Foldvary, N., Mascha, E., Lee, J., Acetazolamide in women with catamenial epilepsy. Epilepsia 42 (2001), 746–749.
101. Magee, L.A., Miremadi, S., Li, J., Cheng, C., Ensom, M.H.H., Carleton, B., et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 193 (2005), 153–163.
102. Makus, K.G., McCormick, J., Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy. Clin Ther 29 (2007), 334–341.
103. Mawer, G., Briggs, M., Baker, G.A., Bromley, R., Coyle, H., Eatock, J., et al. Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure 19 (2010), 112–119.
104. Mawhinney, E., Craig, J., Morrow, J., Russell, A., Smithson, W.H., Parsons, L., et al. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. Neurology 80 (2013), 400–405.
105. Mims, J., Sexuality and related issues in the preadolescent and adolescent female with epilepsy. J Neurosci Nurs 28 (1996), 102–106.
106. Morrow, J., Russell, A., Guthrie, E., Parsons, L., Robertson, I., Waddell, R., et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77 (2006), 193–198.
107. Ornoy, A., Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. Reprod Toxicol 22 (2006), 214–226.
108. Ornoy, A., Valproic acid in pregnancy: how much are we endangering the embryo and fetus?. Reprod Toxicol 28 (2009), 1–10.
109. Pack, A., Bone health in people with epilepsy: is it impaired and what are the risk factors?. Seizure 17 (2008), 181–186.
110. Patel, S.I., Pennell, P.B., Management of epilepsy during pregnancy: an update. Ther Adv Neurol Disord 9 (2016), 118–129.
111. Patsalos, P.N., Drug interactions with the newer antiepileptic drugs (AEDs)—part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders. Clin Pharmacokinet 52 (2013), 1045–1061.
112. Patsalos, P.N., Berry, D.J., Bourgeois, B.F., Cloyd, J.C., Glauser, T.A., Johannessen, S.I., et al. Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 49 (2008), 1239–1276.
113. Pennell, P.B., Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 61 (2003), S35–42.
114. Reimers, A., Contraception for women with epilepsy: counseling, choices, and concerns. Open Access J Contracept 7 (2016), 69–76.
115. Reimers, A., Brodtkorb, E., Sabers, A., Interactions between hormonal contraception and antiepileptic drugs: clinical and mechanistic considerations. Seizure 28 (2015), 66–70.
116. Sabers, A., Buchholt, J.M., Uldall, P., Hansen, E.L., Lamotrigine plasma levels reduced by oral contraceptives. Epilepsy Res 47 (2001), 151–154.
117. Saengsuwan, J., Boonyaleepan, S., Tiamkao, S., Diet, exercise, sleep, sexual activity, and perceived stress in people with epilepsy in NE Thailand. Epilepsy Behav 45 (2015), 39–43.
118. Samokhvalov, A.V., Irving, H., Mohapatra, S., Rehm, J., Alcohol consumption, unprovoked seizures, and epilepsy: a systematic review and meta-analysis. Epilepsia 51 (2010), 1177–1184.
119. Schmidt, D., Canger, R., Avanzini, G., Battino, D., Cusi, C., Beck-Mannagetta, G., et al. Change of seizure frequency in pregnant epileptic women. J Neurol Neurosurg Psychiatry 46 (1983), 751–755.
120. Sheth, R.D., Adolescent issues in epilepsy. J Child Neurol, 17(Suppl. 2), 2002, 2S23-2S27.
121. Shiek Ahmad, B., Hill, K.D., O'Brien, T.J., Gorelik, A., Habib, N., Wark, J.D., Falls and fractures in patients chronically treated with antiepileptic drugs. Neurology 79 (2012), 145–151.
122. Simko, J., Karesova, I., Kremlacek, J., Fekete, S., Zimcikova, E., Malakova, J., et al. The effect of lamotrigine and phenytoin on bone turnover and bone strength: a prospective study in Wistar rats. Epilepsy Res 128 (2016), 113–118.
123. Sukumaran, S.C., Sarma, P.S., Thomas, S.V., Polytherapy increases the risk of infertility in women with epilepsy. Neurology 75 (2010), 1351–1355.
124. Tauboll, E., Sveberg, L., Svalheim, S., Interactions between hormones and epilepsy. Seizure 28 (2015), 3–11.
125. Thomas, S.L., Ellertson, C., Nuisance or natural and healthy: should monthly menstruation be optional for women?. Lancet 355 (2000), 922–924.
126. Thomas, S.V., Ajaykumar, B., Sindhu, K., Nair, M.K., George, B., Sarma, P.S., Motor and mental development of infants exposed to antiepileptic drugs in utero. Epilepsy Behav 13 (2008), 229–236.
127. Tomson, T., The pharmacological treatment of epilepsy in women. Atlas of epilepsies, 2010, 1515–1520.
128. Tomson, T., Battino, D., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 10 (2011), 609–617.
129. Valsamis, H.A., Arora, S.K., Labban, B., McFarlane, S.I., Antiepileptic drugs and bone metabolism. Nutr Metab (Lond), 3, 2006, 36.
130. Veliskova, J., The role of estrogens in seizures and epilepsy: the bad guys or the good guys?. Neuroscience 138 (2006), 837–844.
131. Veliskova, J., Estrogens and epilepsy: why are we so excited?. Neuroscientist 13 (2007), 77–88.
132. Westin, A.A., Reimers, A., Helde, G., Nakken, K.O., Brodtkorb, E., Serum concentration/dose ratio of levetiracetam before, during and after pregnancy. Seizure 17 (2008), 192–198.
133. Williams, G., King, J., Cunningham, M., Stephan, M., Kerr, B., Hersh, J.H., Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 43 (2001), 202–206.
134. Wilner, A.N., Therapeutic equivalency of generic antiepileptic drugs: results of a survey. Epilepsy Behav 5 (2004), 995–998.
135. Zaccara, G., Perucca, E., Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. Epileptic Disord 16 (2014), 409–431.
136. Okoli, C., Pawlowski, S.D., The Delphi method as a research tool: an example, design considerations and applications. Inf Manag 42 (2004), 15–29.
137. Maruthur, N.M., Joy, S.M., Dolan, J.G., Shihab, H.M., Singh, S., Use of the analytic hierarchy process for medication decision-making in type 2 diabetes. PLoS One, 10, 2015, e0126625.
138. Hummel, M.J., Volz, F., van Manen, J.G., Danner, M., Dintsios, C.M., Ijzerman, M.J., et al. Using the analytic hierarchy process to elicit patient preferences: prioritizing multiple outcome measures of antidepressant drug treatment. Patient 5 (2012), 225–237.
139. Saaty, T.L., The analytic hierarchy process: planning, priority setting, resource allocation. 1980, McGraw-Hill International Book Company.
140. Pack, A.M., Should patients with epilepsy be routinely screened for low bone mineral density?. Nat Clin Pract Neurol 4 (2008), 354–355.
141. Ferguson, N.D., Davis, A.M., Slutsky, A.S., Stewart, T.E., Development of a clinical definition for acute respiratory distress syndrome using the Delphi technique. J Crit Care 20 (2005), 147–154.
142. Hancock, R.L., Koren, G., Einarson, A., Ungar, W.J., The effectiveness of Teratology Information Services (TIS). Reprod Toxicol 23 (2007), 125–132.
143. Frost Widnes, S.K., Schjott, J., Drug use in pregnancy—physicians' evaluation of quality and clinical impact of drug information centres. Eur J Clin Pharmacol 65 (2009), 303–308.
144. Koren, G., Bologa, M., Long, D., Feldman, Y., Shear, N.H., Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. Am J Obstet Gynecol 160 (1989), 1190–1194.
145. Sanz, E., Gomez-Lopez, T., Martinez-Quintas, M.J., Perception of teratogenic risk of common medicines. Eur J Obstet Gynecol Reprod Biol 95 (2001), 127–131.
146. Tomson, T., Battino, D., Pregnancy and epilepsy: what should we tell our patients?. J Neurol 256 (2009), 856–862.
147. Albaghdadi, O., Alhalabi, M.S., Alourfi, Z., Youssef, L.A., Bone health and vitamin D status in young epilepsy patients on valproate monotherapy. Clin Neurol Neurosurg 146 (2016), 52–56.
148. Markoula, S., Sioka, C., Exarchopoulos, T., Chatzistefanidis, D., Kalef-Ezra, J., Fotopoulos, A., et al. Gender specific association of decreased bone mineral density in patients with epilepsy. Neurol Neurochir Pol 49 (2015), 267–271.
149. Edwards, R.A., Pharmacists as an underutilized resource for improving community-level support of breastfeeding. J Hum Lact 30 (2014), 14–19.
150. O'Brien, M.D., Gilmour-White, S.K., Management of epilepsy in women. Postgrad Med J 81 (2005), 278–285.
151. Kaaja, E., Kaaja, R., Matila, R., Hiilesmaa, V., Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology 58 (2002), 549–553.